Study of REGN2810 Prior to Surgery in Patients With Advanced-Stage, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck

Condition:   Melanoma and Other Malignant Neoplasms of Skin
Intervention:   Drug: REGN2810
Sponsors:   M.D. Anderson Cancer Center;   Regeneron Pharmaceuticals
Not yet recruiting

https://ift.tt/2trFsoW